Eli Lilly Escapes Testosterone MDL With Settlement Deal

Law360, New York (December 22, 2017, 3:54 PM EST) -- Eli Lilly & Co. told an Illinois federal judge on Thursday it had reached a global settlement in all cases filed against the pharmaceutical company in multidistrict litigation over testosterone replacement therapy products, striking the deal about a month before the company’s first bellwether trial.

Eli Lilly and the consumers told U.S. District Judge Matthew Kennelly that they had entered into a memorandum of understanding, according to a court order. The judge cancelled two upcoming trial dates in January and March over Tracy Garner and John...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.